Loading...

← Back to Leaderboard

Dana P. Goldman

Global rank #2376 97%

Institution: University of Southern California

Primary Field: Health (weighted toward more recent publications)

Homepage: http://healthpolicy.usc.edu

First Publication: 1995

Most Recent: 2021

RePEc ID: pgo681 ↗

Publication Scores

Scores use coauthorship adjustment: α/n credit per paper, where n = number of authors. α = 2.01: calibrated so average adjusted count equals average raw count (a zero-sum adjustment).

Period S (4x) A (2x) B (1x) C (½x) Total
Last 5 Years 0.00 1.01 1.80 0.00 3.81
Last 10 Years 0.00 1.51 2.47 0.00 5.48
All Time 4.36 3.18 10.21 0.00 34.34

Publication Statistics

Raw Publications 29
Coauthorship-Adjusted Count 18.50

Publications (29)

Year Article Journal Tier Authors
2021 The future of the elderly population health status: Filling a knowledge gap Health Economics B 7
2021 Disparate ageing: The role of education and socioeconomic gradients in future health and disability in an international context Health Economics B 3
2021 Disentangling moral hazard and adverse selection in private health insurance Journal of Econometrics A 2
2021 Predicting quantity and quality of life with the Future Elderly Model Health Economics B 4
2021 Improved survival for individuals with common chronic conditions in the Medicare population Health Economics B 6
2020 Political polarization in US residents’ COVID-19 risk perceptions, policy preferences, and protective behaviors Journal of Risk and Uncertainty B 3
2018 Do Physicians Respond to the Costs and Cost-Sensitivity of Their Patients? American Economic Journal: Economic Policy A 4
2014 HETEROGENEITY IN ACTION: THE ROLE OF PASSIVE PERSONALIZATION IN COMPARATIVE EFFECTIVENESS RESEARCH Health Economics B 5
2014 RESPONSE TO EPSTEIN'S COMMENT ON “HETEROGENEITY IN ACTION” Health Economics B 5
2014 The Growing Gap in Life Expectancy: Using the Future Elderly Model to Estimate Implications for Social Security and Medicare American Economic Review S 2
2013 Digesting the doughnut hole Journal of Health Economics B 3
2013 MEDICAL EXPENDITURE RISK AND HOUSEHOLD PORTFOLIO CHOICE Journal of Applied Econometrics B 2
2012 The value of medical and pharmaceutical interventions for reducing obesity Journal of Health Economics B 5
2011 Part D Formulary and Benefit Design as a Risk-Steering Mechanism American Economic Review S 3
2011 How Costly is Hospital Quality? A Revealed‐Preference Approach Journal of Industrial Economics A 2
2010 Criminal Prosecution and Human Immunodeficiency Virus-Related Risky Behavior Journal of Law and Economics B 3
2010 Geographic Variation in Health Care: The Role of Private Markets Brookings Papers on Economic Activity B 5
2010 An economic evaluation of the war on cancer Journal of Health Economics B 6
2010 Valuing health technologies at nice: recommendations for improved incorporation of treatment value in HTA Health Economics B 4
2010 Erratum: Valuing health technologies at NICE: recommendations for improved incorporation of treatment value in HTA Health Economics B 4
2009 Market evidence of misperceived mortality risk Journal of Economic Behavior and Organization B 3
2008 Does age or life expectancy better predict health care expenditures? Health Economics B 2
2007 Integrated Insurance Design in the Presence of Multiple Medical Technologies American Economic Review S 2
2006 HIV Breakthroughs and Risky Sexual Behavior Quarterly Journal of Economics S 3
2005 Socioeconomic Differences in the Adoption of New Medical Technologies American Economic Review S 2
2005 The reallocation of compensation in response to health insurance premium increases Economics Letters C 3
2003 The link between public and private insurance and HIV-related mortality Journal of Health Economics B 3
2000 Queuing for Surgery: Is the U.S. or Canada Worse Off? Review of Economics and Statistics A 3
1995 The effects of benefit design and managed care on health care costs Journal of Health Economics B 4